Perceptive Advisors
Perceptive Advisors

Perceptive Advisors

Investing in transformative life sciences and healthcare innovations for a healthier future.

Website
1999Hedge Fund61 portfolio$9.5B AUMNew York, United States

About

Investing in transformative life sciences and healthcare innovations for a healthier future. Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare.

Key facts

Website
perceptivelife.com
Type
Hedge Fund
Headquarters
New York, United States
Funds raised
$9.5B
Portfolio companies
61
Stages
Series E
Series F
Cheque size
$50M to $250M
Sector focus
Healthcare
Ultrasound
Therapy

Recent investments

Recent funding rounds Perceptive Advisors took part in
DateCompanyRoundAmount
1 Jun 2026ModernaFunding Round$50M
17 Mar 2026Imperative CareSeries E$100M
6 Mar 2026CRISPR TherapeuticsSeries B$140M
1 Dec 2025ModernaGrant$54M
1 Nov 2025ModernaPost-IPO Debt$600M
1 Jul 2024ModernaGrant$176M
18 Jun 2024InsightecSeries F$150M
1 Mar 2024ModernaPost-IPO Equity$750M
13 Feb 2024CRISPR TherapeuticsPost IPO$280M
13 Nov 2023GeneDxUndisclosed round$150M
Add first review

Frequently asked

What companies has Perceptive Advisors invested in?

Perceptive Advisors has invested in Moderna, Imperative Care, CRISPR Therapeutics, Insightec, GeneDx and 56 more.

AUM
$9.5B
PORTFOLIO
61